Pegylated interferons alpha2a and alpha2b in the treatment of chronic hepatitis C.

Nature Reviews. Gastroenterology & Hepatology
Alessio AghemoMassimo Colombo

Abstract

Chronic infection with HCV has an estimated prevalence of 1.6-2.0% worldwide and is a major cause of liver-related death. The first attempts to halt the progression of infection relied on the empirical use of interferon (IFN), a naturally occurring cytokine that is implicated in antiviral innate immunity. The first studies of this treatment in the early 1990s, however, led to disappointing response rates. These response rates subsequently improved with the empirical addition of the guanosine analog ribavirin to the treatment regimen. To improve the effectiveness and tolerability of the three times per week therapeutic schedule of IFN, two forms of pegylated interferon (PEG-IFN) were developed in the early 2000s-PEG-IFN-alpha2a and PEG-IFN-alpha2b. These two compounds differ markedly in size, structure, site of attachment of the polyethylene glycol moiety and type of bond involved in pegylation, which ultimately confer different pharmacokinetics and biological activity. Unsurprisingly, researchers question whether the two PEG-IFNs also differ in clinical effectiveness, but the re-analysis of restrospective studies and the results of three head-to-head studies have left this issue open. We have, therefore, scrutinized the design ...Continue Reading

References

Sep 21, 1991·JAMA : the Journal of the American Medical Association·S BaronT K Hughes
Dec 18, 1986·The New England Journal of Medicine·J H HoofnagleE A Jones
Jan 1, 1993·Advances in Virus Research·G C Sen, R M Ransohoff
Apr 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M Peters
Dec 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M RumiM Colombo
Aug 21, 2001·Clinical Pharmacokinetics·J M HarrisM Modi
Oct 5, 2001·Clinical Microbiology Reviews·C E Samuel
Jan 19, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M GraceR Bordens
Sep 5, 2002·Nature Reviews. Immunology·Michael G KatzeMichael Gale
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Oct 3, 2002·Gastroenterology·John G McHutchisonUNKNOWN International Hepatitis Interventional Therapy Group
Dec 7, 2002·Nature Immunology·Paul SheppardKevin M Klucher
Aug 23, 2003·Seminars in Liver Disease·Simon C J Pedder
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group
Oct 14, 2004·Alimentary Pharmacology & Therapeutics·G R Foster
Jan 14, 2005·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Paolo Caliceti
Feb 26, 2005·Seminars in Liver Disease·Jean-Michel Pawlotsky
Jun 14, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Yoav LurieRan Oren
Jul 8, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xing Xian YuSanjay Bhanot
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jean-Michel Pawlotsky
May 17, 2006·Annals of Internal Medicine·Gregory L ArmstrongMiriam J Alter
Nov 28, 2006·Journal of Hepatology·Subrat Kumar AcharyaSubrat Kumar Panda
Jan 2, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·K Rajender ReddyMichael Fried
Feb 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Savino BrunoUNKNOWN Italian Association of the Study of the Liver Disease (AISF)
Mar 6, 2007·Journal of Hepatology·Cristina BosettiCarlo La Vecchia
Jun 15, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maria Serena LonghiDiego Vergani
Jun 15, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lisa I BackusLarry A Mole
Sep 27, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ira M JacobsonUNKNOWN WIN-R Study Group
Nov 21, 2007·Journal of Hepatology·Juan I EstebanJosep Quer
Jul 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stefan ZeuzemJohn G McHutchison
Aug 22, 2008·Journal of Hepatology·Annika KauChristoph Sarrazin
Feb 24, 2009·Journal of Hepatology·Jennifer M Croswell, Barnett S Kramer
Mar 28, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Nancy McGreal, Donald M Jensen
May 1, 2009·The New England Journal of Medicine·John G McHutchisonUNKNOWN PROVE1 Study Team
May 1, 2009·The New England Journal of Medicine·Christophe HézodeUNKNOWN PROVE2 Study Team
Jul 25, 2009·The New England Journal of Medicine·John G McHutchisonUNKNOWN IDEAL Study Team
Aug 12, 2009·Journal of Hepatology·Silvio Garattini, Vittorio Bertele'
Sep 15, 2009·Nature Genetics·Vijayaprakash SuppiahJacob George
Sep 18, 2009·Nature·David L ThomasMary Carrington

❮ Previous
Next ❯

Citations

Dec 12, 2012·Advanced Drug Delivery Reviews·Taslim A Al-HilalYoungro Byun
Feb 15, 2011·Clinical Therapeutics·Elena VezaliMassimo Colombo
Apr 12, 2012·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Eleonora Aricò, Filippo Belardelli
May 17, 2011·Chemistry Central Journal·Yasuo YoshiokaYasuo Tsutsumi
Oct 14, 2011·Viruses·Marlène Dreux, Francis V Chisari
Aug 11, 2012·Hepatitis Monthly·Roberta D'Ambrosio, Alessio Aghemo
Oct 23, 2012·Hepatitis Monthly·Hisham O AkbarMaha Al Rumani
Dec 23, 2011·Expert Opinion on Biological Therapy·Mauro ViganòMassimo Colombo
Dec 1, 2011·Expert Opinion on Investigational Drugs·Peter L M Jansen, Joep De Bruijne
Jan 29, 2013·Expert Opinion on Biological Therapy·Carolina Scagnolari, Guido Antonelli
Jan 22, 2011·Expert Opinion on Biological Therapy·Elena VezaliMassimo Colombo
Apr 16, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Victoria A SubletteKathryn Nicholson Perry
Apr 30, 2015·PloS One·Renuka SubramaniamHomayoun Shams
Feb 28, 2017·Antiviral Research·Guangdi Li, Erik De Clercq
May 1, 2013·Expert Review of Anti-infective Therapy·Elisabetta DegasperiMassimo Colombo
Jan 7, 2020·Médecine sciences : M/S·Alicia ContetPeter Lowe
Jan 15, 2014·Journal of Leukocyte Biology·Deann T SnyderJodi F Hedges
Mar 12, 2013·Organic & Biomolecular Chemistry·Walter MierUwe Haberkorn
Apr 21, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ying-Zi YeHui Yu
Jun 9, 2021·Journal of Clinical Immunology·Donald C VinhUNKNOWN COVID Human Genetic Effort
Apr 13, 2012·Journal of the American Chemical Society·Mathew W JonesDavid M Haddleton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.